ZIEXTENZO

This brand name is authorized in Austria, Australia, Canada, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Lithuania, Netherlands, New Zealand, Poland, Romania, United Kingdom, United States

Active ingredients

The drug ZIEXTENZO contains one active pharmaceutical ingredient (API):

1 Pegfilgrastim UNII 3A58010674 - PEGFILGRASTIM

Pegfilgrastim is a sustained duration form of filgrastim due to decreased renal clearance. Pegfilgrastim and filgrastim have been shown to have identical modes of action, causing a marked increase in peripheral blood neutrophil counts within 24 hours, with minor increases in monocytes and/or lymphocytes. Read about Pegfilgrastim

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L03AA13	Pegfilgrastim	L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AA Colony stimulating factors
Discover more medicines within L03AA13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 6363X, 9514R
Country: CA	Health Products and Food Branch	Identifier(s): 02497395
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 206-MBE-0721
Country: EE	Ravimiamet	Identifier(s): 1782907
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1181327001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 400318
Country: FR	Base de données publique des médicaments	Identifier(s): 63626633
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 366099
Country: HK	Department of Health Drug Office	Identifier(s): 67124
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1086768
Country: NL	Z-Index G-Standaard	Identifier(s): 15007219
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 68756
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 20542
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100416364
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65254001
Country: US	FDA, National Drug Code	Identifier(s): 61314-866